Julia G. Butchko
Corporate Officer/Principal chez IMMUNOVANT, INC.
Fortune : 15 M $ au 31/03/2024
Profil
Julia G.
Butchko is currently the Chief Development Officer at Immunovant, Inc. She previously worked at Eli Lilly & Co. as the Chief of Staff from 2018 to 2019.
Dr. Butchko completed her undergraduate degree at The State University of New York College at Fredonia and holds a doctorate degree from The Pennsylvania State University.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
IMMUNOVANT INC
0,31% | 17/04/2024 | 451 627 ( 0,31% ) | 15 M $ | 31/03/2024 |
Postes actifs de Julia G. Butchko
| Sociétés | Poste | Début |
|---|---|---|
| IMMUNOVANT, INC. | Corporate Officer/Principal | 01/04/2023 |
Anciens postes connus de Julia G. Butchko
| Sociétés | Poste | Fin |
|---|---|---|
| ELI LILLY AND COMPANY | Human Resources Officer | 01/06/2019 |
Formation de Julia G. Butchko
| The State University of New York College at Fredonia | Undergraduate Degree |
| The Pennsylvania State University | Doctorate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 2 |
|---|---|
| ELI LILLY AND COMPANY | Health Technology |
| IMMUNOVANT, INC. | Health Technology |
